Brenntag (BNR) Receives €57.71 Consensus Price Target from Analysts

Shares of Brenntag (FRA:BNR) have received an average recommendation of “Buy” from the nineteen research firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and eleven have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is €57.71 ($68.70).

Several brokerages recently weighed in on BNR. Goldman Sachs set a €56.00 ($66.67) price objective on Brenntag and gave the stock a “neutral” rating in a research report on Wednesday, March 14th. Berenberg Bank set a €57.00 ($67.86) price objective on Brenntag and gave the stock a “neutral” rating in a research report on Thursday, March 8th. UBS set a €53.00 ($63.10) price target on Brenntag and gave the company a “neutral” rating in a research note on Monday, February 5th. Baader Bank set a €62.00 ($73.81) price target on Brenntag and gave the company a “buy” rating in a research note on Friday, February 2nd. Finally, equinet set a €59.80 ($71.19) price target on Brenntag and gave the company a “buy” rating in a research note on Wednesday, March 14th.

Brenntag traded down €0.06 ($0.07), hitting €50.74 ($60.40), during trading on Monday, according to MarketBeat. The stock had a trading volume of 297,787 shares. Brenntag has a one year low of €43.06 ($51.26) and a one year high of €56.25 ($66.96).

Brenntag Company Profile

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply